Cargando…
The prevalence, risk factors, and prognostic value of venous thromboembolism in ovarian cancer patients receiving chemotherapy: a systematic review and meta-analysis
BACKGROUND: Venous thromboembolism (VTE) in ovarian cancer (OC) patients has been widely investigated, but our knowledge on the role of VTE in OC patients receiving chemotherapy is limited. The aim of our study was to investigate the prevalence, risk factors, and prognostic value of chemotherapy-ass...
Autores principales: | Ye, Lu, Cai, Li, Fu, Yonghui, Zhuang, Debao, Hu, Xiaoqing, Jie, Youkun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7807708/ https://www.ncbi.nlm.nih.gov/pubmed/33441137 http://dx.doi.org/10.1186/s12957-020-02101-5 |
Ejemplares similares
-
MicroRNA miR-330-3p suppresses the progression of ovarian cancer by targeting RIPK4
por: Cai, Li, et al.
Publicado: (2021) -
The risk of venous thromboembolism in cancer patients receiving chemotherapy: a meta-analysis with systematic review
por: Bao, Yun, et al.
Publicado: (2021) -
Incidence of venous thromboembolism following the neoadjuvant chemotherapy regimen for epithelial type of ovarian cancer
por: Chavan, Devendra Manik, et al.
Publicado: (2017) -
ELFN1-AS1 accelerates cell proliferation, invasion and migration via regulating miR-497-3p/CLDN4 axis in ovarian cancer
por: Jie, Youkun, et al.
Publicado: (2020) -
Characteristic and Prognostic Implication of Venous Thromboembolism in Ovarian Clear Cell Carcinoma: A 12-Year Retrospective Study
por: Ye, Shuang, et al.
Publicado: (2015)